Thayne Woycinck Kowalski Selected Research

Fetal Diseases (Embryopathy)

7/2023	A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors.
12/2022	Genetic evaluation of HAND2 gene and its effects on thalidomide embryopathy.
1/2021	Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy.
1/2020	CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation.
1/2019	Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?
1/2018	Genetic susceptibility to thalidomide embryopathy in humans: Study of candidate development genes.
1/2017	The impact of thalidomide use in birth defects in Brazil.
1/2017	Angiogenesis-related genes and thalidomide teratogenesis in humans: an approach on genetic variation and review of past in vitro studies.
12/2016	Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.
3/2016	New Findings in eNOS gene and Thalidomide Embryopathy Suggest pre-transcriptional effect variants as susceptibility factors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thayne Woycinck Kowalski Research Topics

Disease

11	Fetal Diseases (Embryopathy) 07/2023 - 09/2015
5	Teratogenesis 04/2024 - 03/2016
2	Neoplasms (Cancer) 01/2024 - 03/2016
2	Erythema Nodosum 01/2022 - 01/2021
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 04/2016
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Adenocarcinoma of Lung 01/2024
1	Leiomyoma (Uterine Fibroids) 01/2024
1	Muscular Atrophy (Muscle Atrophy) 01/2024
1	Disease Progression 01/2024
1	Zika Virus Infection 01/2022
1	Multiple Myeloma 01/2020
1	Congenital Abnormalities (Deformity) 01/2017
1	Leprosy (Hansen's Disease) 01/2017
1	Sepsis (Septicemia) 04/2016

Drug/Important Bio-Agent (IBA)

13	Thalidomide (Thalomid)FDA Link 04/2024 - 09/2015
3	TeratogensIBA 01/2022 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2024
1	FollistatinIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	MyostatinIBA 01/2024
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	CateninsIBA 01/2017
1	Fc gamma receptor IIAIBA 04/2016

Therapy/Procedure

1	Denervation 01/2024
1	Muscle Denervation 01/2024
1	Therapeutics 01/2024